Literature DB >> 12098640

Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant.

Masanori Takehashi1, Seigo Tanaka, Eliezer Masliah, Kunihiro Ueda.   

Abstract

The association between (GT)n dinucleotide repeats in monoamine oxidase gene loci, monoamine oxidase A (MAOA) and B (MAOB), and Parkinson's disease (PD), Alzheimer's disease (AD), and Lewy body variant (LBV) of AD were determined. MAOA-GT polymorphisms were significantly associated with pure AD and LBV. MAOA-GT allele 113 was excessively represented in pure AD and LBV compared with controls. Furthermore, the frequency of females homozygous for MAOA-GT allele 113 was higher in pure AD and LBV than controls by 2.79- and 2.77-fold, respectively. In contrast, there was no association between MAOA-GT or MAOB-GT polymorphisms and PD. These results suggest that polymorphisms within the MAOA gene may have implication in AD pathology shared by pure AD and LBV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098640     DOI: 10.1016/s0304-3940(02)00258-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation.

Authors:  Zelan Wei; Tamara Satram-Maharaj; Bradley Chaharyn; Kelly Kuski; Paul R Pennington; Xia Cao; Jennifer Chlan; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2012-03-03       Impact factor: 3.575

2.  Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro.

Authors:  Paul R Pennington; Zelan Wei; Lewei Rui; Jennifer A Doig; Brett Graham; Kelly Kuski; Geraldine G Gabriel; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2011-03-04       Impact factor: 3.575

3.  Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells.

Authors:  Dalip Sethi; Chang-Po Chen; Rui-Yan Jing; Mathew L Thakur; Eric Wickstrom
Journal:  Bioconjug Chem       Date:  2012-01-25       Impact factor: 4.774

Review 4.  Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.

Authors:  Makoto Naoi; Peter Riederer; Wakako Maruyama
Journal:  J Neural Transm (Vienna)       Date:  2015-01-22       Impact factor: 3.575

5.  The Histone H3 K4me3, K27me3, and K27ac Genome-Wide Distributions Are Differently Influenced by Sex in Brain Cortexes and Gastrocnemius of the Alzheimer's Disease PSAPP Mouse Model.

Authors:  Francesca Casciaro; Giuseppe Persico; Martina Rusin; Stefano Amatori; Claire Montgomery; Jennifer R Rutkowsky; Jon J Ramsey; Gino Cortopassi; Mirco Fanelli; Marco Giorgio
Journal:  Epigenomes       Date:  2021-11-25

Review 6.  The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease.

Authors:  Daniele Caligiore; Flora Giocondo; Massimo Silvetti
Journal:  IBRO Neurosci Rep       Date:  2022-09-26

7.  Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology.

Authors:  Xia Cao; Zelan Wei; Geraldine G Gabriel; XinMin Li; Darrell D Mousseau
Journal:  BMC Neurosci       Date:  2007-09-16       Impact factor: 3.288

8.  The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.

Authors:  Keliang Wang; Jie Luo; Shuyuan Yeh; Bosen You; Jialin Meng; Philip Chang; Yuanjie Niu; Gonghui Li; Changxue Lu; Yezi Zhu; Emmanuel S Antonarakis; Jun Luo; Chi-Ping Huang; Wanhai Xu; Chawnshang Chang
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.